Echo Therapeutics retains Hayden IR

FRANKLIN, MA: Echo Therapeutics, a medical device and specialty pharmaceuticals company, has retained Hayden IR as it nears the completion of two new products.

FRANKLIN, MA: Echo Therapeutics, a medical device and specialty pharmaceuticals company, has retained Hayden IR as it nears the completion of two new products: Prelude SkinPrep, a skin permeation platform technology, and Symphony tCGM, a needle-free glucose monitoring system. The firm will develop an IR campaign promoting Echo's strategic vision, reputation, and competitive strengths.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in